LivaNova appoints Brooke Story to its Board of Directors

– UK, London –  LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the appointment of Brooke Story to its Board of Directors, effective September 15, 2022.

“Over the course of her career, Brooke has excelled in helping large medical device corporations inspire their teams, mentor and develop talent, and deliver economic value. Her insight will prove valuable to the Board as we work to guide the company toward continued growth and success,” said Board Chair, William Kozy.

Brooke Story will also join the Nominating and Corporate Governance Committee.

About Brooke Story

Brooke Story joins the LivaNova Board with more than 20 years of experience in the global medical technology industry. She currently serves as Worldwide President, Integrated Diagnostic Solutions at BD a position she assumed in April 2021. Prior to that, she spent 15 years at Medtronic, where she held a variety of roles in finance, sales and business unit leadership, culminating in her tenure as President, Pelvic Health and Gastric Therapies. Story also spent a portion of her early career in sales at Johnson & Johnson.

“LivaNova has a clear and demonstrated commitment to patients’ quality of life,” said Brooke Story. “I look forward to working with the Board to support the company’s innovation and ongoing delivery of life-changing medical technologies.”

About LivaNova

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to providing hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 3,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide.

For more information: https://www.livanova.com/en-us

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.